Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Transition of Combivent Respimat is nearly complete as Boehringer Ingelheim plans to cease distribution of Combivent MDI in May.
Breo Ellipta is a novel combination inhaler indicated for the maintenance of COPD, including chronic bronchitis and/or emphysema.
Since April 2012, a novel coronavirus (NCoV) has infected 31 adults in six countries.
For preterm infants, administration of the monoclonal antibody palivizumab for prevention of respiratory syncytial virus (RSV) infection is associated with a significant reduction in the number of days of wheezing during the first year of life.
